![David R. Staskin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David R. Staskin
Direktor/Vorstandsmitglied bei Inpellis, Inc.
Aktive Positionen von David R. Staskin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Inpellis, Inc.
![]() Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Direktor/Vorstandsmitglied | 01.01.2015 | - |
Unternehmenssekretär | 01.01.2015 | - |
Karriereverlauf von David R. Staskin
Ausbildung von David R. Staskin
Cornell University | Undergraduate Degree |
Drexel University College of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 1 |
Corporate Secretary | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Inpellis, Inc.
![]() Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Health Technology |
- Börse
- Insiders
- David R. Staskin
- Erfahrung